Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Sequenom offers genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides a nucleic acid analysis platform that measures genetic target material and variations.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 8, 2001 | Grant | $2.20M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |